In summary, our findings demonstrate that the activation of the c-Abl/TFEB pathway represents a common pathogenic mechanism in pharmacological cellular models of Gaucher, NPA, and NPC diseases. Here, ABL1 is linked to nasopharyngeal carcinoma.